The Parenteral Nutrition by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Parenteral Nutrition Market:
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report
According to The Business Research Company’s Parenteral Nutrition, The parenteral nutrition market size has grown strongly in recent years. It will grow from $6.48 billion in 2023 to $6.85 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising disposable income and urbanization, growing obese population and increasing popularity of noninvasive and minimally invasive aesthetic procedures.
The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $8.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing elderly population, rapid urbanization and rise in disposable income, increase in mergers and acquisitions. Major trends in the forecast period include product innovations, use of artificial intelligence in aesthetics, development of focal radio frequency technology, use of laser-assisted liposuction, and partnerships and collaborations.
The growing prevalence of malnutrition across the globe is driving the growth of the parenteral nutrition market. Malnutrition refers to deficiencies, excesses, or imbalances in a person’s intake of energy or nutrients. Premature births, which result in immune dysfunction and inadequate nutrition, have increased the demand for and use of parenteral nutrition among children and infants. For example, according to the World Health Organization, a Switzerland-based government agency, in 2021, 1.9 billion adults were overweight or obese, while 462 million were underweight. Around 45% of deaths among children under 5 years of age are linked to undernutrition. Hence, the growing prevalence of malnutrition across the globe is expected to boost demand for parenteral nutrition during the forecast period.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=6705&type=smp
The parenteral nutrition market covered in this report is segmented –
1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions
2) By Consumer Type: Children and New-born, Adults
3) By End-User: Hospitals, Clinics, Homecare, Other End Users
Product innovation is a major trend in the parental nutrition market. Companies in the parental nutrition market are introducing innovative products, such as four-oil lipid injectable emulsion, to expand the parenteral nutrition portfolio. For instance, in March 2022, Fresenius Kabi, a Germany-based pharmaceutical company, received approval from the United States Food and Drug Administration (US FDA) for SMOFlipid lipid injectable emulsion for pediatric parenteral nutrition, including term and preterm neonates. The SMOFlipid lipid injectable emulsion is the first and only four-oil lipid injectable emulsion that contains soybean oil, medium-chain triglycerides, olive oil, and fish oil, a good source of omega-3 fatty acids. It can be used from the hospital to the home care setting.
The parenteral nutrition market report table of contents includes:
1. Executive Summary
2.Parenteral Nutritio Characteristics
3. Parenteral Nutritio Trends And Strategies
4. Parenteral Nutritio Market Analysis.
5.Parenteral Nutritio Market Size And Growth
6. Parenteral NutritioSegmentation
7. Parenteral NutritioRegional And Country Analysis
.
.
.
27. Parenteral NutritioCompetitive Landscape And Company Profiles
28. Parenteral NutritioKey Mergers And Acquisitions
29. Parenteral NutritioFuture Outlook and Potential Analysis
TOP MAJOR PLAYERS:
B. Braun Melsungen AG,
Baxter International Inc,
Eli Lilly and Company,
Fresenius Kabi AG,
Option Care Health Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
